Sam Kettel, Associate Director, Corporate Communications at Neurocrine Biosciences

Sam Kettel

Associate Director, Corporate Communications at Neurocrine Biosciences | United States

Profile last verified July 2026
Public Relations & Communications Verified Profile United States University of California, Santa Barbara
Verified

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

(***) ***-*343

United States • Phone

Free account · No credit card · 5 profiles/month

Sam Kettel Socials
Sam Kettel Work Experience

Associate Director, Corporate Communications at Neurocrine Biosciences in January 2020 - Present

Account Supervisor at Lovell Communications in October 2015 - January 2020

Senior Account Executive at Bradford Group in October 2013 - October 2015

See more See less

Account Executive at Weber Shandwick in January 2011 - June 2013

eMedia Intern at Rogers & Cowan in September 2010 - December 2010

Communication and Public Affairs Intern for VH1, CMT and Logo TV at Viacom in June 2010 - September 2010

PR/Advertising Director at WORD Magazine in September 2008 - June 2010

Entertainment Marketing Intern at St. Jude Children's Research Hospital in June 2009 - September 2009

Sam Kettel Education

University of California, Santa Barbara, Bachelor of Arts, January 2007 to January 2010

William S. Hart High School, January 2003 to January 2007

Sam Kettel Skills
Media Relations Event Planning Cision Public Relations Social Media Marketing Publicity Facebook Media Monitoring Research Special Events Writing Social Media Measurement Press Kits Television Strategic Communications Healthcare Healthcare Marketing Social Media
About Sam Kettel’s Current Company
Neurocrine Biosciences

Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. Review our Community Guidelines: https://bit.ly/NeurocrineLinkedInGuidelines *in collaboration with AbbVie

Discover more about Neurocrine Biosciences
Sam Kettel’s Colleagues
Denise Prindiville

Denise Prindiville

Pensacola, Florida, United States

Vice President @ Neurocrine Biosciences | Organizational Leadership, Team Building

Vice President at Neurocrine Biosciences
(May 2024 – Present)

Saya Godwin

Saya Godwin

San Diego, California, United States

Executive Director, Sourcing & Procurement @ Neurocrine Biosciences | MBA in Operations

Executive Director, Sourcing & Procurement at Neurocrine Biosciences
(June 2022 – Present)

Ileana Slavin

Ileana Slavin

San Diego, California, United States

Neurocrine Biosciences

Principal Scientist - Tissue Culture Technologies at Neurocrine Biosciences
(February 2023 – Present)

Nahad Berenji

Nahad Berenji

Scottsdale, Arizona, United States

Regional Patient Access Manager, Pharm D., BCGP, RPh

Regional Patient Access Manager at Neurocrine Biosciences
(August 2021 – Present)

Satjit Brar

Satjit Brar

San Diego, California, United States

Vice President at Neurocrine Biosciences

Vice President, Preclinical and Clinical Pharmacology at Neurocrine Biosciences
(May 2024 – Present)

Henry Cheng

Henry Cheng

San Mateo, California, United States

Senior Director of Health Economics & Outcomes Research at Neurocrine Biosciences

Senior Director of Health Economics & Outcomes Research at Neurocrine Biosciences
(July 2024 – Present)

Search similar profiles
Frequently asked questions about Sam Kettel

What is Sam Kettel email address?

Email Sam Kettel at [email protected] and [email protected]. This email is the most updated Sam Kettel's email found in 2026.

How to contact Sam Kettel?

To contact Sam Kettel send an email to [email protected] or [email protected].

What company does Sam Kettel work for?

Sam Kettel works for Neurocrine Biosciences.

What is Sam Kettel's role at Neurocrine Biosciences?

Sam Kettel is Associate Director, Corporate Communications

What industry does Sam Kettel work in?

Sam Kettel works in the Public Relations & Communications industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free